The use of an IL-1 receptor antagonist peptide to control inflammation in the treatment of corneal limbal epithelial stem cell deficiency.
about
Potential Mediators between Fibromyalgia and C-Reactive protein: Results from a Large U.S. Community Survey.Influence of interleukin-1 beta gene polymorphisms on the risk of myocardial infarction and ischemic stroke at young age in vivo and in vitro.Inflammatory Response to Lipopolysaccharide on the Ocular Surface in a Murine Dry Eye Model.Autologous Limbal Stem Cell Transplantation: The Progression of Diagnosis and Treatment.Limbal and corneal epithelial homeostasis.Identification of Peptide Antagonists to Thioredoxin Glutathione Reductase of Schistosoma japonicum.
P2860
The use of an IL-1 receptor antagonist peptide to control inflammation in the treatment of corneal limbal epithelial stem cell deficiency.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The use of an IL-1 receptor an ...... ithelial stem cell deficiency.
@en
type
label
The use of an IL-1 receptor an ...... ithelial stem cell deficiency.
@en
prefLabel
The use of an IL-1 receptor an ...... ithelial stem cell deficiency.
@en
P2860
P356
P1476
The use of an IL-1 receptor an ...... pithelial stem cell deficiency
@en
P2093
P2860
P304
P356
10.1155/2015/516318
P407
P577
2015-02-01T00:00:00Z